Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,921 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab.
Toboso I, Tejeda-Velarde A, Alvarez-Lafuente R, Arroyo R, Hegen H, Deisenhammer F, Sainz de la Maza S, Alvarez-Cermeño JC, Izquierdo G, Paramo D, Oliva P, Casanova B, Agüera-Morales E, Franciotta D, Gastaldi M, Fernández O, Urbaneja P, Garcia-Dominguez JM, Romero F, Laroni A, Uccelli A, Perez-Sempere A, Saiz A, Blanco Y, Galimberti D, Scarpini E, Espejo C, Montalban X, Rasche L, Paul F, González I, Álvarez E, Ramo C, Caminero AB, Aladro Y, Calles C, Eguía P, Belenguer-Benavides A, Ramió-Torrentà L, Quintana E, Martínez-Rodríguez JE, Oterino A, López de Silanes C, Casanova LI, Landete L, Frederiksen J, Bsteh G, Mulero P, Comabella M, Hernández MA, Espiño M, Prieto JM, Pérez D, Otano M, Padilla F, García-Merino JA, Navarro L, Muriel A, Frossard LC, Villar LM. Toboso I, et al. Among authors: perez sempere a, perez d. Front Neurol. 2020 Dec 17;11:579438. doi: 10.3389/fneur.2020.579438. eCollection 2020. Front Neurol. 2020. PMID: 33408681 Free PMC article.
Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab.
Villar LM, Costa-Frossard L, Masterman T, Fernandez O, Montalban X, Casanova B, Izquierdo G, Coret F, Tumani H, Saiz A, Arroyo R, Fink K, Leyva L, Espejo C, Simó-Castelló M, García-Sánchez MI, Lauda F, Llufriú S, Álvarez-Lafuente R, Olascoaga J, Prada A, Oterino A, de Andrés C, Tintoré M, Ramió-Torrentà L, Rodríguez-Martín E, Picón C, Comabella M, Quintana E, Agüera E, Díaz S, Fernandez-Bolaños R, García-Merino JA, Landete L, Menéndez-González M, Navarro L, Pérez D, Sánchez-López F, Serrano-Castro PJ, Tuñón A, Espiño M, Muriel A, Bar-Or A, Álvarez-Cermeño JC. Villar LM, et al. Among authors: perez d. Ann Neurol. 2015 Mar;77(3):447-57. doi: 10.1002/ana.24345. Epub 2015 Jan 30. Ann Neurol. 2015. PMID: 25581547
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers.
Muñoz D, Escartín A, Dapena D, Coret F, Fernández-Uría D, Pérez D, Casanova B, Guijarro-Castro C, Munteis E, del-Campo Amigo M, Pego R, Calles C, García-Rey C, Monsalve N, Sánchez-Matienzo D. Muñoz D, et al. Among authors: perez d. BMC Neurol. 2013 Jul 11;13:82. doi: 10.1186/1471-2377-13-82. BMC Neurol. 2013. PMID: 23845043 Free PMC article.
Genomic Evolution of the SARS-CoV-2 Omicron Variant in Córdoba, Argentina (2021-2022): Analysis of Uncommon and Prevalent Spike Mutations.
Olivero NB, Zappia VE, Gargantini P, Human-Gonzalez C, Raya-Plasencia L, Marquez J, Ortiz-Batsche L, Hernandez-Morfa M, Cortes PR, Ceschin D, Nuñez-Fernandez M, Perez DR, Echenique J. Olivero NB, et al. Among authors: perez dr. Viruses. 2024 Dec 3;16(12):1877. doi: 10.3390/v16121877. Viruses. 2024. PMID: 39772187 Free PMC article.
Data Resource Profile: Harmonized health survey data for 240 cities across 11 countries in Latin America: the SALURBAL project.
Moore K, Lazo M, Ortigoza A, Quistberg DA, Sanchez B, Acharya B, Alfaro T, Kroker-Lobos MF, Menezes MC, Sarmiento OL, de Souza Andrade AC, Perez Ferrer C, Hernandez Vasquez A, Caiaffa WT, Diez Roux AV; SALURBAL Group. Moore K, et al. Int J Epidemiol. 2024 Dec 16;54(1):dyae171. doi: 10.1093/ije/dyae171. Int J Epidemiol. 2024. PMID: 39761604 Free PMC article. No abstract available.
Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks.
Suárez-García I, Alejos B, Moreno C, Martín Torres J, Masiá M, García-Fraile LJ, Riera M, Dalmau D, Rodríguez-Rosado R, Muga R, Moreno S, Jarrín I; CoRIS cohort. Suárez-García I, et al. J Antimicrob Chemother. 2024 Dec 23:dkae456. doi: 10.1093/jac/dkae456. Online ahead of print. J Antimicrob Chemother. 2024. PMID: 39710424
Unveiling pandemic patterns: a detailed analysis of transmission and severity parameters across four COVID-19 waves in Bogotá, Colombia.
Quevedo DS, Domínguez NT, Perez DF, Cabrera Polanía MA, Serrano Medina JD, Abril-Bermúdez FS, Romero DM, Rios Oliveros DS, González Mayorga MA, Whittaker C, Cucunubá ZM. Quevedo DS, et al. Among authors: perez df. BMC Glob Public Health. 2024 Dec 10;2(1):83. doi: 10.1186/s44263-024-00105-x. BMC Glob Public Health. 2024. PMID: 39681974 Free PMC article.
1,921 results